The latest news:

• Brain Tumor Webinar Series: Gamma Knife Radiosurgery Sunday, 9/16/18         Dr Schulder will be speaking about the new version of the Gamma Knife, but will also answer questions on any brain tumor related topic!
  



• Intra-tumoral treatment with oxygen-ozone in glioblastoma: A systematic literature search and results of a case series         Interesting results, but in a small number of patients.
  



• Researchers make breakthrough in understanding aggressive brain cancer         Researchers at Duke identified why brain tumor patients have such low t cell counts - as low as that of AIDs patients.  Now we just need to figure out how to use this information!
  



• Moleculin’s Brain Cancer Drug Candidate Begins Patient Dosing at Clinical Trial Being Conducted at MD Anderson         This is a new STAT3 inhibitor. STAT3 has been known as a god target for brain tumors but until now we did not have a good drug to target it. This was just the first in human doses of the drug so it is way too early to tell if it will work, but it may become an important tool in the ultimate cocktail.
  



• Effects of tumor treating fields (TTFields) on glioblastoma cells are augmented by mitotic checkpoint inhibition.         I am a big fan of Optune. It is the most effective approved treatment for gbms,  but it is not good enough by itself. We need to find ways to make it work better.  There are about 16 clinical trials going on now that involve Optune and ways to make it work better.   Any of these trials are worthwhile to try.  Experiments like this are needed to identify candidates for the trials. 
  

BrainTumor Co-Payment Assistance Program Status:

• Almost closed to new applicants - Call first